VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Adult males and females who are 18 years of age or │ Adult males and females who are 18 years of age or │     100 │
│ older                                              │ older                                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Evidence or suspicion of upper gastrointestinal    │ Evidence or suspicion of upper gastrointestinal    │     100 │
│ bleed (GIB)                                        │ bleed (GIB)                                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient with known or suspected cirrhosis          │ Patient with known or suspected cirrhosis          │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Upper GIB secondary to bleeding esophageal varices │ Upper GIB secondary to bleeding esophageal varices │     100 │
│ as show by esophageal endoscopy, requiring         │ as show by esophageal endoscopy, requiring         │         │
│ endoscopic band ligation (EBL) at presentation     │ endoscopic band ligation (EBL) at presentation     │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Willing and able to provide informed consent for   │ Willing and able to provide informed consent for   │     100 │
│ study, or have a Legally authorized representative │ study, or have a Legally authorized representative │         │
│ (LAR) provide consent if the patient is unable to  │ (LAR) provide consent if the patient is unable to  │         │
│ do so                                              │ do so                                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Known upper gastrointestinal malignancy            │ Known upper gastrointestinal malignancy            │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Bleeding from gastric varices, with or without     │ Bleeding from gastric varices, with or without     │     100 │
│ esophageal varices                                 │ esophageal varices                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Use of any other endoscopic method to stop GI      │ Use of any other endoscopic method to stop GI      │     100 │
│ bleeding beyond endoscopic band ligation           │ bleeding beyond endoscopic band ligation           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Variceal bleeding in the last 90 days              │ Variceal bleeding in the last 90 days              │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History of transjugular, intrahepatic,             │ History of transjugular, intrahepatic,             │     100 │
│ portosystemic shunt (TIPS) or vascular             │ portosystemic shunt (TIPS) or vascular             │         │
│ decompression surgery                              │ decompression surgery                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Pregnant females                                   │ Pregnant females                                   │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Incarcerated individuals                           │ Incarcerated individuals                           │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Myocardial infarct, cerebrovascular accident,      │ Myocardial infarct, cerebrovascular accident,      │     100 │
│ sepsis, respiratory failure, or severe             │ sepsis, respiratory failure, or severe             │         │
│ intercurrent illness within the previous 6 weeks   │ intercurrent illness within the previous 6 weeks   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Non-cirrhotic portal hypertension causing          │ Non-cirrhotic portal hypertension causing          │     100 │
│ esophageal varices                                 │ esophageal varices                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Known or suspected allergy to octreotide           │ Known or suspected allergy to octreotide           │     100 │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                      │   Score │
╞═══════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years │ Adult males and females who are 18 years of age or │      45 │
│                                   │ older                                              │         │
╘═══════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 98
Average Levenshtein Ratio of individual lines: 96.5625
OverAll Ratio: 97.28125
